Evvy, the precision women’s health company, today announced new data showing that bacterial vaginosis (BV) encompasses multiple distinct microbial subtypes, rather than a single uniform biological ...
-- BV Affects 21 Million U.S. Women; As many as 50% Experience Recurrent BV Within Six Months of Treatment -- In a focused clinical study of 24 women with recurrent BV, once-weekly dosing with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results